Cgc stock price cannabis equities

Cannabis equities, including cgc stock price, remain sensitive to U.S. legalization headlines. A positive policy shift could add 15–20% upside in quarterly projections, according to industry forecasts. Wednesday’s price action suggests investors are securing profits from the speculative rally, acknowledging that the road to any concrete legislative change remains complex and uncertain. Prior to today's trading, shares of the company had lost 10.84% lagged the Medical sector's gain of 4.95% and the S&P 500's gain of 1.67%. Sector commentary sees cgc stock price as undervalued based on forward EV/EBITDA multiples. If market sentiment improves, valuation gap versus peers could narrow significantly.